$200K in New Funding: Breast Cancer Canada Matched Grant
Breast Cancer Canada and AstraZeneca Canada launched new matched grant funding opportunity for research dedicated to improving treatment options for metastatic breast cancer.
The 2025 call for grants: “Uncovering Predictive Markers and Mechanisms of Treatment Resistance in Advanced HR+ and HER2+ Breast Cancer” opened this summer with the opportunity for two $100,000 awards for Canadian research labs.
At BCC’s Canadian Night at ESMO 2025, the selected research recipients were announced.

















